Year: 2015
Resolution Number: 10
Action Taken: Referred to the Board
Status:
Author(s): Anne-Mare Ice, MD
Sponsor: Anne-Mare Ice, MD
On behalf of:
Committee: E (Science and Education Affairs)
Resolved Section(s):
RESOLVED: That MSMS work with the American Medical Association to assess and develop a coordinated system of care for individual patients who need coordinated clinical care of their pain management rather than stigmatization as an abuser of narcotics or as a high-utilizer; and be it further RESOLVED: That the American Medical Association amend policy H-95.947 as follows:H-95.947 Prescription Drug Monitoring to Prevent Abuse of Controlled SubstancesOur AMA: (1) supports the refinement of state-based prescription drug monitoring programs and development and implementation of appropriate technology to allow for Health Insurance Portability and Accountability Act (HIPAA)-compliant sharing of information on prescriptions for controlled substances among states, PHARMACIES, AND CLINICIANS; (2) policy is that the sharing of information on prescriptions for controlled substance with out-of-state entities should be subject to same criteria and penalties for unauthorized use as in-state entities; (3) actively supports the funding of the National All Schedules Prescription Electronic Reporting Act of 2005 which would allow federally funded, interaoperative, state based prescription drug monitoring programs as a tool for addressing patient misuse and diversion of controlled substances; (4) encourages and supports the prompt development of, with appropriate privacy safeguards, treating physician’s real time access to their patient’s controlled substances prescriptions ACROSS STATE BOUNDARIES; and (5) advocates that any information obtained through these programs be used first for education of the specific physicians involved prior to any civil action against these physicians; and be it further RESOLVED: That, consistent with the American Medical Association (AMA) policies H-95.945 and H-95.947, the AMA implement a coordinated effort among all state medical societies to advocate for an interstate compact whereby, pharmacies and clinicians can have access to Prescription Drug Monitoring Programs controlled substances dispensing data across state boundaries.
RESOLVED: That MSMS work with the American Medical Association to assess and develop a coordinated system of care for individual patients who need coordinated clinical care of their pain management rather than stigmatization as an abuser of narcotics or as a high-utilizer; and be it further RESOLVED: That the American Medical Association amend policy H-95.947 as follows:H-95.947 Prescription Drug Monitoring to Prevent Abuse of Controlled SubstancesOur AMA: (1) supports the refinement of state-based prescription drug monitoring programs and development and implementation of appropriate technology to allow for Health Insurance Portability and Accountability Act (HIPAA)-compliant sharing of information on prescriptions for controlled substances among states, PHARMACIES, AND CLINICIANS; (2) policy is that the sharing of information on prescriptions for controlled substance with out-of-state entities should be subject to same criteria and penalties for unauthorized use as in-state entities; (3) actively supports the funding of the National All Schedules Prescription Electronic Reporting Act of 2005 which would allow federally funded, interaoperative, state based prescription drug monitoring programs as a tool for addressing patient misuse and diversion of controlled substances; (4) encourages and supports the prompt development of, with appropriate privacy safeguards, treating physician’s real time access to their patient’s controlled substances prescriptions ACROSS STATE BOUNDARIES; and (5) advocates that any information obtained through these programs be used first for education of the specific physicians involved prior to any civil action against these physicians; and be it further RESOLVED: That, consistent with the American Medical Association (AMA) policies H-95.945 and H-95.947, the AMA implement a coordinated effort among all state medical societies to advocate for an interstate compact whereby, pharmacies and clinicians can have access to Prescription Drug Monitoring Programs controlled substances dispensing data across state boundaries.
Fiscal Note: NULL
Resolution: View PDF for Managing Controlled Substance High Utilizer Patients
For More Information, Contact: